These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8429501)
1. Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects. Roth W; Bauer E; Heinzel G; Cornelissen PJ; van Tol RG; Jonkman JH; Zuiderwijk PB J Pharm Sci; 1993 Jan; 82(1):99-106. PubMed ID: 8429501 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of falipamil after intravenous administration to humans. Roth W; Koss FW; Hallinan D; Lambe R; Darragh A J Pharm Sci; 1990 May; 79(5):415-9. PubMed ID: 2352161 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers. Blight AR; Henney HR Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Nave R; Bethke TD; van Marle SP; Zech K Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects. Schmid J; Busch U; Heinzel G; Bozler G; Kaschke S; Kummer M Drug Metab Dispos; 1995 Nov; 23(11):1206-13. PubMed ID: 8591720 [TBL] [Abstract][Full Text] [Related]
6. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817 [TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers. Kramer WG; Nagabhushan N; Affrime MB; Perentesis GP; Symchowicz S; Patrick JE J Clin Pharmacol; 1988 Jul; 28(7):644-8. PubMed ID: 3216030 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Disposition, and Biotransformation of [ Trivedi A; Wahlstrom J; Mackowski M; Dutta S; Lee E Drug Metab Dispos; 2021 Aug; 49(8):619-628. PubMed ID: 34011533 [TBL] [Abstract][Full Text] [Related]
10. Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjects. Shah B; Emmons G; Rohatagi S; Martin NE; Jensen BK Am J Ther; 2003; 10(5):356-62. PubMed ID: 12975720 [TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
12. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil. Muirhead GJ; Rance DJ; Walker DK; Wastall P Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):13S-20S. PubMed ID: 11879255 [TBL] [Abstract][Full Text] [Related]
13. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs. Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676 [TBL] [Abstract][Full Text] [Related]
14. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
16. Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants. Devineni D; Murphy J; Wang SS; Stieltjes H; Rothenberg P; Scheers E; Mamidi RN Clin Pharmacol Drug Dev; 2015 Jul; 4(4):295-304. PubMed ID: 27136910 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49. Mukai H; Watanabe S; Morino A Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106 [TBL] [Abstract][Full Text] [Related]
18. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man. Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659 [TBL] [Abstract][Full Text] [Related]
19. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose. Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]